Epigenetic mechanisms connected to therapeutic vulnerability and clinical outcome in liver cancer.

Published Date: 17 May 2023

Dr. Dot Manel Esteller's team at the Josep Carreras Leukemia Research Institute has identified a significant epigenetic change that predicts the clinical course of liver cancer. The NSUN7 has now been deactivated.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot